why are high-quality standardized databases so critical for drug development?
Published 4 years ago • 34 plays • Length 4:12Download video MP4
Download video MP3
Similar videos
-
0:58
rick liwski - why are data standards important?
-
2:27
jane larkindale - why are c-path drug development tools important in rare disease drug development?
-
5:18
what is exciting to you about taking on this ambitious project?
-
4:07
what is exciting to you about taking on this ambitious project?
-
2:26
how does trxa help bridge the drug development "valley of death?"
-
29:30
accelerating drug development for rare diseases through data sharing and analysis
-
4:10
martha brumfield - why is sharing data so important?
-
2:04:49
rare diseases aggregated data bases to inform drug development research
-
10:43
ibd webinar 2021: biomarker development: opportunities in inflammatory bowel
-
0:52
rick liwski - how often is data updated?
-
26:24
critical path institute: 15 years of impact
-
8:22
why is this platform useful and relevant to the prader-willi community?
-
21:20
2021 rdca-dap annual workshop: optimization of a clinical scale for use as a regulatory endpoint (1)
-
3:48
how has the presence or lack of data changed drug development for platelet disorders?
-
48:02
rdca-dap - value of integrated data and analytics in rare disease drug development
-
0:37
diane stephenson - why is c-path so important in the drug development space?
-
1:34:43
eatx rdca-dap - webinar on ‘data sharing and analysis to support rare disease drug development‘
-
4:33
the drug development process
-
3:27
what does the fda hope to achieve through developing the rare disease cures accelerator?